Evaluating Menopause and Women's Telehealth Programs
Evaluate menopause and women’s telehealth affiliate opportunities by audience, service scope, availability, program terms and approved promotional copy.
Read the guideTelehealth / Women's Health / HRT & Menopause
Category 03 · Private access
HRT and Menopause Telehealth Affiliate Programs
Millions of women in perimenopause and menopause are looking for clinicians who take their symptoms seriously, and many find them online. Here's how menopause telehealth programs work, which publishers they suit, and how to write about hormone therapy responsibly.
Last reviewed October 4, 2026
Private HRT offersTerms and creative unlock after approval.
The opportunity
Menopause care has long been underserved. Many women report symptoms being dismissed, and few clinicians specialize in it. Telehealth programs that focus on perimenopause and menopause give these patients access to clinicians who do, with treatment plans that can include hormone therapy, non-hormonal options and lifestyle support.
The audience researches deeply, reads long content, subscribes to newsletters and trusts creators who speak honestly about their own experience. That makes it one of the best fits in telehealth for content publishers, newsletters and podcasts, and a category where quality content still ranks.
Who the patients are: women, mostly in their 40s and 50s, researching symptoms such as hot flashes, sleep problems and mood changes, comparing options and looking for a clinician who listens.
How menopause telehealth programs work
A patient completes a health history, often with a symptom assessment, and meets a licensed clinician by video or message. The clinician recommends a plan, which may include FDA-approved hormone therapy, compounded hormones where the clinician and pharmacy decide it's appropriate, non-hormonal prescriptions, or no medication at all. Memberships cover follow-ups and adjustments.
| Program type | What the patient gets | Typical conversion event |
|---|---|---|
| Menopause specialist membership | Ongoing clinician access, treatment plan and prescriptions if appropriate | First paid month |
| Single consultation | A one-time visit and plan, with optional follow-up | Booked or completed consult |
| Broader women's health | Menopause care alongside other women's health services | Membership sign-up or completed intake |
CPA on the first paid month and CPL on completed intakes are both common here, with revenue share for programs with long memberships. Terms are shared with approved publishers.
The 2026 label changes, and how to write about them
In November 2025 FDA began removing boxed warnings about cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels. On February 12, 2026 it approved the change for the first six FDA-approved products, with more companies' requests pending.
It's a big story and good material for content. But it applies to specific FDA-approved products, not to hormone therapy in general and not to compounded hormones. Write about it as news, link to the source, and don't turn it into "HRT is now safe" or "risk-free". Every patient's risks are still assessed by a clinician.
Best-fit traffic
- SEO content: symptom explainers, treatment overviews, "how to find a menopause doctor" guides and program comparisons with disclosure.
- Newsletters and communities: women's health and midlife newsletters with opt-in audiences, and moderated communities where promotion is allowed.
- Podcasts and creators: personal stories told honestly, with clear disclosure and approved talking points.
- YouTube: explainer content with clinicians or informed hosts.
Paid search and paid social are approval-required, as with every prescription category.
Category rules
Do
- Say a licensed clinician recommends the treatment plan
- Present hormone therapy as one option among several
- Mention that treatment involves benefits and risks discussed with a clinician
- Link to sources when citing research or FDA news
- Disclose your affiliate relationship clearly
Don't
- Call hormone therapy safe, risk-free or side-effect free
- Claim compounded or "bioidentical" hormones are safer or more natural without approved, substantiated wording
- Promise relief from specific symptoms or a timeline
- Apply FDA label news to compounded products
- Present a symptom quiz as a diagnosis
More detail is in the HRT section of the compliance guide.
How to evaluate a menopause program before you promote it
Your audience is trusting you with a personal health decision. Before promoting a menopause program, check:
- Clinician expertise: are clinicians trained or experienced in menopause care?
- Treatment range: does the program offer FDA-approved options and non-hormonal alternatives, not only compounded hormones?
- Risk discussion: does the intake cover personal and family history so a clinician can assess risks?
- Follow-up: are there scheduled check-ins to adjust treatment?
- Pricing and cancellation: are costs and renewal terms clear, with easy online cancellation?
- Licensed states and certification: where can it treat patients, and does it hold LegitScript certification for paid ads?
Programs that do these things well earn reviews, referrals and long memberships, which is what makes this audience valuable to both sides.
Content that works and stays compliant
- Symptom guides: what perimenopause and menopause can look like, with "talk to a clinician" as the next step.
- Treatment options explained: hormone therapy, non-hormonal prescriptions and lifestyle approaches, balanced and sourced.
- The 2026 label changes, explained: what changed, which products, and what it doesn't mean.
- How to find menopause care online: what a good program offers and the questions to ask.
- Program comparisons: clinician expertise, follow-up, pricing and cancellation terms, with disclosure.
Tip: this audience shares content that respects them. Honest, sourced writing earns links, newsletter forwards and long-term rankings, which matter more here than short-term clicks.
Part of women's health: menopause and HRT sit within the women's telehealth category, alongside PCOS, contraception and vaginal health programs. Each advertiser sets its own eligibility, so check the brief before you describe who a program is for.
For advertisers: run a menopause or women's health program and want vetted publishers? Tell us about your program and we'll reply within one business day. Share your program details.
FAQ
HRT affiliate questions
What are HRT affiliate programs?
Partnerships where publishers earn a commission for referring patients to telehealth menopause programs, where a licensed clinician may recommend hormone therapy or other treatment. On MarketHealth these offers are private and available to approved publishers.
Can I say FDA removed the warnings on HRT?
You can report the news accurately: FDA approved removing certain boxed warnings from specific FDA-approved menopausal hormone therapy products in February 2026. Don't generalize it to all hormone therapy or to compounded hormones, and don't call HRT safe.
Can I promote compounded or bioidentical hormone programs?
Only with the advertiser's approved wording. Don't claim compounded or bioidentical hormones are safer, more natural or more effective unless the advertiser has substantiated, approved language for it.
Which publishers do best with menopause offers?
Women's health content sites, midlife newsletters, podcasts and creators with an engaged audience in their 40s and 50s who already disclose sponsorships.
How do HRT offers pay?
Commonly CPA on the first paid month or CPL on completed intakes, with revenue share for long memberships. Terms are shared after approval.
Private access
Bring your audience. We'll bring the offers worth promoting.
Telehealth offers on MarketHealth are available by approval only. Applications are reviewed by a person, not a script.
Private offers. Publisher approval first.
MarketHealth has programs in this category. Apply through our Telehealth Publishers page to discuss the campaigns suited to your audience.
Advertiser identities, payouts, creatives, tracking links and campaign-specific terms are shared privately after the relevant approval. This page is a publisher recruitment resource, not a consumer treatment or pharmacy order page.
Who this category fits
This category is relevant to midlife women’s-health publishers, newsletters and creators.
A useful editorial angle
Describe consultation access and individualized assessment without implying every patient needs hormone therapy.
What your private brief will confirm
Clinical service scope, eligible patients, available states and approved medication language.
Your brief also identifies approved traffic sources, landing pages, required disclosures and the conversion event used for attribution.
From application to approved campaign
- Review the publisher requirements and apply through the Telehealth Publishers page.
- Discuss your audience, websites, channels and service areas with the MarketHealth team.
- Receive the campaign-specific brief and approved tracking links after review.